Each row is a biotech company with active signals from FDA filings, SEC disclosures, clinical trial databases, and insider trading records. Use the filters below to surface the companies worth researching before the market moves.
A–F letter grade based on the quality and timing of upcoming catalysts — PDUFA dates, AdCom votes, Phase 3 readouts. A = multiple near-term high-impact events. F = nothing on the calendar.
0–100 composite measuring signal density across all data sources. A score of 80+ means multiple independent signals are firing simultaneously — insider buys, clinical activity, and an approaching FDA date, for example.
A scheduled event with a known date that can move a biotech stock significantly — FDA approval decisions (PDUFA), advisory committee votes (AdCom), Phase 2/3 trial data readouts, and earnings.
Tags showing which data sources fired. PDUFA = approval date. Insider Buy = executive bought shares. Convergence = StonkWhisper momentum aligned with fundamentals. Dilution = SEC filing suggests offering risk.
DilutionWatch score (0–100) measuring SEC-filing evidence of upcoming share dilution. CRITICAL = active S-3/ATM shelf, offering likely this quarter. LOW = healthy balance sheet, no shelf detected.
Estimated months of cash remaining at the current burn rate from DilutionWatch. A company cannot survive to its PDUFA date without cash. Under 6 months = likely to raise capital soon.
| Ticker↕ | Company↕ | Sector↕ | Score▼ | Grade↕ | DW Risk↕ | Cash↕ | Signals | Next Catalyst↕ | |
|---|---|---|---|---|---|---|---|---|---|
| AQUA | Aquestive Therapeutics | CNS | 92.63 | A | — | — | — | — | |
| ARCH | Arctus Therapeutics | Inflammatory | 92.55 | A | — | — | — | — | |
| BIS | Biosign Technologies | Cardiovascular Diagnostics | 92.55 | A | — | — | — | — | |
| BIOS | BioSig Technologies | Cardiac Electrophysiology | 92.32 | A | — | — | — | — | |
| ADIL | Adial Pharmaceuticals, Inc | Biotech / Pharma | 91.68 | A | — | — | — | — | |
| ANTE | AntriaBio | Endocrinology | 91.68 | A | — | — | — | — | |
| INVO | INVO Bioscience | Infertility IVF | 91.63 | A | — | — | — | — | |
| EMED | Edgemont Pharmaceuticals | Pediatric CNS | 87.72 | A | — | — | — | — | |
| AGIO | Agios Pharmaceuticals | Rare Disease | 85.68 | A | — | — | — | — | |
| AIM | AIM ImmunoTech Inc. | Immunology | 85.43 | A | — | — | — | — | |
| HAO | Haoxi Health Technology Limited Class A | Biotech / Pharma | 83.38 | A | — | — | — | — | |
| PBM | Psyence Biomedical Ltd. Common Shares | Biotech / Pharma | 82.76 | A | — | — | — | — | |
| MGM | MGM Resorts International | RNA Therapy | 81.91 | A | — | — | — | — | |
| NCI | Neo-Concept International Group Holdings Limited Class A | RNA Therapy | 81.72 | A | — | — | — | — | |
| ATRA | Atara Biotherapeutics | Cell Therapy | 81.66 | A | — | — | — | — | |
| IKT | Inhibikase Therapeutics, Inc. | Biotech / Pharma | 81.54 | A | — | — | — | — | |
| PALI | Palisade Bio, Inc. | Biotech / Pharma | 81.28 | A | — | — | — | — | |
| MPT | Medical Properties Trust, Inc. | Biotech / Pharma | 81.26 | A | — | — | — | — | |
| CHH | Choice Hotels International, Inc. | RNA Therapy | 81.25 | A | — | — | — | — | |
| CUE | Cue Biopharma, Inc. | Biotech / Pharma | 81.16 | A | — | — | — | — | |
| LAB | Standard BioTools Inc. | Biotech / Pharma | 81.09 | A | — | — | — | — | |
| ARDT | Ardent Health, Inc. | Biotech / Pharma | 81.06 | A | — | — | — | — | |
| DRUG | Bright Minds Biosciences Inc. | Biotech / Pharma | 81.06 | A | — | — | — | — | |
| IMA | ImageneBio, Inc. | Biotech / Pharma | 80.98 | A | — | — | — | — | |
| MFI | mF International Limited Class A | RNA Therapy | 80.97 | A | — | — | — | — | |
| MAIA | MAIA Biotechnology, Inc. | Biotech / Pharma | 80.89 | A | — | — | — | — | |
| TRT | Trio-Tech International | RNA Therapy | 80.79 | A | — | — | — | — | |
| VNO | Vornado Realty Trust | RNA Therapy | 80.72 | A | — | — | — | — | |
| ACH | Accendra Health, Inc. | Biotech / Pharma | 80.51 | A | — | — | — | — | |
| OGEN | Otonomy Inc | Ear Drug Delivery | 80.51 | A | — | — | — | — | |
| BYRN | Byrna Technologies, Inc. | RNA Therapy | 80.48 | A | — | — | — | — | |
| CDNA | CareDx Inc | Transplant | 80.38 | A | — | — | — | — | |
| SAVA | Cassava Sciences | Neuroscience | 80.38 | A | — | — | — | — | |
| DH | Definitive Healthcare Corp. | Biotech / Pharma | 80.31 | A | — | — | — | — | |
| HRMY | Harmony Biosciences | Neuroscience | 80.24 | A | — | — | — | — | |
| INO | Inovio Pharmaceuticals, Inc. | Biotech / Pharma | 80.24 | A | — | — | — | — | |
| AIN | Albany International Corporation | RNA Therapy | 80.21 | A | — | — | — | — | |
| VANI | Vivani Medical, Inc. | Biotech / Pharma | 79.87 | B | — | — | — | — | |
| MBX | Microbix Biosystems | Viral Antigens Diagnostics | 79.84 | B | — | — | — | — | |
| CIX | CompX International Inc. | RNA Therapy | 79.66 | B | — | — | — | — | |
| AMAG | AMAG Pharmaceuticals | Hematology | 79.47 | B | — | — | — | — | |
| ICU | SeaStar Medical Holding Corporation | Biotech / Pharma | 79.41 | B | — | — | — | — | |
| NHI | National Health Investors, Inc. | Biotech / Pharma | 79.36 | B | — | — | — | — | |
| PROF | Profound Medical | Image-guided Ablation | 79.35 | B | — | — | — | — | |
| JAZZ | Jazz Pharmaceuticals plc | Biotech / Pharma | 79.21 | B | — | — | — | — | |
| RAMP | LiveRamp Holdings, Inc. | Liver Disease | 79.21 | B | — | — | — | — | |
| PMI | Picard Medical, Inc. | Biotech / Pharma | 79.01 | B | — | — | — | — | |
| GRI | GRI Bio, Inc. | Biotech / Pharma | 78.89 | B | — | — | — | — | |
| CAMP | CAMP4 Therapeutics Corporation | Biotech / Pharma | 78.88 | B | — | — | — | — | |
| SBC | SBC Medical Group Holdings Incorporated | Biotech / Pharma | 78.88 | B | — | — | — | — |
Not financial advice. Data by Guerilla Finance Inc. for informational purposes only. Always conduct your own due diligence.